Business

Imagion to complete the MagSense HER2 Phase 1 Study

Imagion to complete the MagSense HER2 Phase 1 Study

Imagion Biosystems Ltd.June 20, 20235
Imagion to complete the MagSense HER2 Phase 1 Study

About this update from Imagion Biosystems Ltd.

Imagion Biosystems Ltd has released a press release. View Attachment

View stock analysis, news, and events for Imagion Biosystems Ltd.

More from Imagion Biosystems Ltd.

All Imagion Biosystems Ltd. news →